How to get the best view of the Portland Timbers match against the LA Galaxy on Sunday

The Portland Timbers have faced two MLS Cup champions in MLS Cup history and two MLS Super Bowl champions.

They’ve also played in the MLS Cup Finals in 2005 and 2013, the first of which ended in a draw.

But with two weeks to go until the season opener, the Timbers will have to be on their game if they’re going to make it out of the group stage.

They need to get a win on Sunday and they’ll need it against the Galaxy.

Portland has only lost one of its past six games, and they haven’t lost to a team with a winning record in three of those.

LA Galaxy forward Robbie Keane scored twice in Sunday’s 2-1 loss, giving him eight goals in his past 10 games for the Galaxy, who will play their first game at StubHub Center on Saturday.

They’re coming off a loss at Seattle on Saturday and haven’t scored in four games, while Seattle’s defense has allowed six goals in its past three games.

The Galaxy (3-6-5) have lost three of their past four games.

They were shut out twice by Sporting Kansas City on Saturday, including in the first half when Keane was sent off in the 87th minute for a dangerous challenge on defender Dan Kennedy.

It was the first yellow card in a game this season for the Sounders.

“They played well, but it’s a game we’ve got to play,” Galaxy head coach Curt Onalfo said.

“We’ve got three games left, and we’ve just got to come out and play good soccer.”

The Timbers have scored three goals in their past two games, including two in the last five minutes.

That’s not good enough to overcome a Galaxy team that’s scored 11 goals in the past five games.

“When we’re playing well, we score goals,” defender Omar Gonzalez said.

How the World’s Most Expensive Drug War Became the Most Expensive

The World Health Organization’s (WHO) annual report for 2017 is the latest salvo in its battle against the drug industry.

The World Trade Organization (WTO) had approved more than 1.5 million pharmaceuticals, the most since the 1970s, and the UN’s World Health Assembly (WHOHAS) had unanimously approved 1.3 million, the highest number since 1992.

This is despite the fact that the WHO’s report, released last week, revealed a record number of deaths and serious medical conditions due to prescription opioids worldwide.

The WHO’s most recent data, from 2017, also found that nearly 4 million people died of prescription drug overdoses in the United States alone.

However, it is the pharmaceutical industry’s lobbying prowess that is driving the push for more drug war policies, particularly in Europe.

The pharmaceutical industry, which is pushing for the U.S. to lift its ban on exports of its opioids, is hoping to pressure the European Union (EU) to allow imports of its painkillers.

The EU, which has an estimated $20 trillion in annual sales, has long been a leading advocate of the drug war, and now it has a new ally in its fight against the opioid crisis.

The drug industry has lobbied hard for the passage of the opioid legislation in the European Parliament, which passed the bill in June.

The lobbying group for the pharmaceuticals industry, the European Commission, has been actively lobbying European countries to allow their citizens to obtain drugs from the United Kingdom.

It has also pushed for increased access to prescription drugs in the U